Evidence map›Paper›PMID 34925043›Full record

ArticleFrontiers in pharmacology2021

The L1624Q Variant in

Laura B Jones, Colin H Peters, Richard E Rosch, Maxine Owers, Elaine Hughes, Deb K Pal, Peter C Ruben

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Laura B JonesDepartment of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
Colin H PetersDepartment of Physiology and Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Richard E RoschMRC Centre for Neurodevelopmental Disorders, King's College London, London, United Kingdom.
Maxine OwersDepartment of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
Elaine HughesDepartment of Paediatric Neurosciences, King's College Hospital, London, United Kingdom.
Deb K PalMRC Centre for Neurodevelopmental Disorders, King's College London, London, United Kingdom.
Peter C RubenDepartment of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
Simon Fraser University · CAKing's College London · GBKing's College Hospital · GBUniversity of Colorado Anschutz Medical Campus · US

Funding

Medical Research Council MR/N026063/1
6 · The paper itself

Abstract

Variants of the

Indexed as

childhood epilepsygain of functionloss of functionSCN1A variantsodium channelopathies

Identifiers

PMID34925043
PMCPMC8675213
OpenAlexW3215578117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.